Rilonacept Regeneron (previously Arcalyst) Európska únia - slovenčina - EMA (European Medicines Agency)

rilonacept regeneron (previously arcalyst)

regeneron uk limited - rilonacept - cryopyrin-spojené periodické syndrómy - imunosupresíva - rilonacept regeneron je indikovaný na liečbu periodické syndrómy asociované s kryopyrínom (caps) s ťažkými príznakmi, vrátane familiárnej studené auto-zápalový syndróm (fcas) a muckleovho-studne syndróm (mws) u dospelých a detí vo veku 12 rokov a staršie.

Libtayo Európska únia - slovenčina - EMA (European Medicines Agency)

libtayo

regeneron ireland designated activity company (dac) - cemiplimab - karcinóm, šquamózna bunka - antineoplastické činidlá - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

Lanvis Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

lanvis

aspen pharma trading limited, Írsko - tioguanín - 44 - cytostatica

Legalon 70 Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

legalon 70

viatris healthcare limited, Írsko - silymarín - 80 - hepatica

Legalon 140 Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

legalon 140

viatris healthcare limited, Írsko - silymarín - 80 - hepatica

Xaluprine (previously Mercaptopurine Nova Laboratories) Európska únia - slovenčina - EMA (European Medicines Agency)

xaluprine (previously mercaptopurine nova laboratories)

nova laboratories ireland limited - 6-merkaptopurín monohydrát - leukémia, lymfóza - antineoplastické činidlá - xaluprin je indikovaný na liečbu akútnej lymfoblastickej leukémie (all) u dospelých, dospievajúcich a detí.

Imasup 50 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

imasup 50 mg

bausch health ireland limited, Írsko - azatioprín - 59 - immunopraeparata

Imasup 25 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

imasup 25 mg

bausch health ireland limited, Írsko - azatioprín - 59 - immunopraeparata